Pfizer Secures US$2.09 B Licensing Agreement for YaoPharma’s Weight Management Candidate
By Hitesh Udar
Pharma Deals Review: Vol 2025 Issue 12 (Table of Contents)
Published: 18 Dec-2025
DOI: 10.3833/pdr.v2025.i12.2986 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Pfizer has entered into a strategic licensing agreement with China’s YaoPharma to advance next-generation therapies for obesity and metabolic diseases...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS